ENTA

Enanta Pharmaceuticals, Inc. Press Releases

$42.03
*  
0.64
1.55%
Get ENTA Alerts
*Delayed - data as of Aug. 27, 2015  -  Find a broker to begin trading ENTA now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ENTA Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2015
8/6/2015 4:01:00 PM - Business Wire
▼-9.48 % Price Change since this news event. The Volume Ratio is 2.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Enanta Pharmaceuticals to Host Conference Call to Discuss Financial Results for the Fiscal Third Quarter and Nine-Months Ended June 30, 2015
7/30/2015 4:30:00 PM - Business Wire
▼-15.94 % Price Change since this news event. The Volume Ratio is 0.34.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Enanta Pharmaceuticals Announces U.S. Regulatory Approval of TECHNIVIE™ (ombitasvir, paritaprevir and ritonavir) tablets
7/24/2015 2:50:00 PM - Business Wire
▼-8.87 % Price Change since this news event. The Volume Ratio is 2.38.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


CORRECTING and REPLACING Enanta Pharmaceuticals Announces the Appointment of Nathalie Adda, M.D. as Chief Medical Officer
6/30/2015 7:30:00 AM - Business Wire
▼-3.29 % Price Change since this news event. The Volume Ratio is 1.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Enanta Pharmaceuticals Announces the Appointment of Nathalie Adda, M.D. as Chief Medical Officer
6/30/2015 7:30:00 AM - Business Wire
▼-3.29 % Price Change since this news event. The Volume Ratio is 1.63.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Enanta Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
6/16/2015 8:00:00 AM - Business Wire
▼-2.73 % Price Change since this news event. The Volume Ratio is 0.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day